Showing results (621-630 of 2,823) with videos related to

Sort By:
Pageof 283
Cytotherapy|July 1, 2025
Yield-driven approach optimizes apheresis of CD19 chimeric antigen receptor-T cell therapy for patients with lymphomaTomoyasu Jo, Toshio Kitawaki, Takashi Sakamoto, et al.
Cytotherapy|September 13, 2025
PSCA-CAR-NK cells exert cytotoxic activity against PSCA-expressing tumor cells and are characterized by a specific chemokine profileRodion A Velichinskii, Maria A Streltsova, Julia D Vavilova, et al.
Cytotherapy|August 19, 2025
Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseasesLindsay C Davies, Lucie Biard, Damián García-Olmo, et al.
Cytotherapy|June 17, 2025
Artificial intelligence, machine learning, and digitalization systems in the cell and gene therapy sector: a guidance document from the ISCT industry committeesVincenzo Di Cerbo, Hannah W Song, Laura Herbst, et al.
Cytotherapy|June 10, 2025
Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering CommitteeLinda Oppizzi, Kinga Hosszu, Susan Prockop, et al.
Cytotherapy|June 21, 2025
Considerations driving the choice in clinical trial design of cell and gene therapy products: weighing convenience versus necessityKeith Abrams, Alessandro Aiuti, Hans-Georg Eichler, et al.
Cytotherapy|June 8, 2025
The donor genetic determinant of human thymopoiesis rs2204985 is associated with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipientsLucas C M Arruda, Ahmed Gaballa, Marie Schaffer, et al.
Cytotherapy|June 3, 2025
Dark NKnight rising: a current perspective on NK cell and CAR-NK cell therapyJoseph R Caporale, Meisam Naeimi Kararoudi, Margaret G Lamb, et al.
Cytotherapy|March 5, 2024
The expanding role of blood and tissue establishments in the development of advanced therapy medicinal productsAisling Horan, Shada Warreth, Tor Hervig, et al.
Cytotherapy|February 16, 2024
Source of hematopoietic progenitor cells determines their capacity to generate innate lymphoid cells ex vivoSaid Z Omar, Vera van Hoeven, Nienke J E Haverkate, et al.
Pageof 283